02 September 2022: Clinical Research
Comparative Evaluation of 3 Commercial Mouthwash Formulations on Clinical Parameters of Chronic Gingivitis
Shahabe Saquib Abullais 1ABFG , Sabiha Ilyas Patel 2ADEF , Elyas Ali Asiri 3ABCE , Adel Ali Ahmed Jathmi 3ABE , Afnan Hassan Alkhayri 3ADEG , Yosra Mohammed Mousa 3BEFG , Atheer Abdulhade Ganem 4BCE , Khurshid A. Mattoo 5CDE*DOI: 10.12659/MSM.937111
Med Sci Monit 2022; 28:e937111
Table 1 Demographic characteristics of study participants and their distribution status between the groups.
| Parameter | Divisions | Group 1 (CHX) (n=15)n (%) | Group 2 (Manuka) (n=15)n (%) | Group 3 (ProD) (n=15)n (%) | Total | Chi square testP-value |
|---|---|---|---|---|---|---|
| Gender | Male | 8 (53.3%) | 9 (60.0%) | 7 (46.7%) | 24 | χ=0.535 (NS)P=.76501 |
| Female | 7 (46.7%) | 6 (40.0%) | 8 (53.3%) | 21 | ||
| Age | 21–25 | 3 (20.0%) | 4 (26.7%) | 5 (33.3%) | 11 | χ=0.5455 (NS)P=.9972 |
| 26–30 | 4 (26.7%) | 3 (20.0%) | 4 (26.7%) | 11 | ||
| 31–35 | 4 (26.7%) | 4 (26.7%) | 3 (20.0%) | 12 | ||
| 36–40 | 4 (26.6%) | 4 (26.6%) | 3 (20.0%) | 11 | ||
| CHX – chlorhexidine; ProD – prodental probiotic; n – number. Level of significance: NS (non-significant)=P≥0.05; * P | ||||||